University Hospital Gent — Ghent

Public research footprint of University Hospital Gent, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Duchenne Muscular Dystrophy (DMD) · Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma · Malignant Neoplasm of Cardio-esophageal Junction of Stomach · Osteosarcoma in Adolescents and Young Adults

Recently updated registry entries

NCT06571149 — Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and… (Recruiting)
NCT05291091 — Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) (Active Not Recruiting)
NCT06066580 — Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy (Enrolling By Invitation)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University Hospital Gent?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.